Hiroko Matsunaga

Hiroko Matsunaga

Auto-generated profile, based on publicly available information

Hiroko Matsunaga

Research Organization for Nano and Life Innovation, Waseda University, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2003 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
HMHiroko Matsunaga
Hiroko Matsunaga
TATakashi Anazawa
Takashi Anazawa
EYEdward S. Yeung
Edward S. Yeung

1 November 2024 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
CXChang Xiao
Chang Xiao
KIKeigo Ide
Keigo Ide
HMHiroko Matsunaga
Hiroko Matsunaga
MKMasato Kogawa
Masato Kogawa
RWRyota Wagatsuma
Ryota Wagatsuma
HTHaruko Takeyama
Haruko Takeyama

3 January 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
TNTram Anh Vu Nguyen
Tram Anh Vu Nguyen
CLCaroline Antunes Lino
Caroline Antunes Lino
HHHuynh Thuy Hang
Huynh Thuy Hang
JAJuliano Vilela Alves
Juliano Vilela Alves
TBThang Quoc Bui
Thang Quoc Bui
HYHiromi Yanagisawa
Hiromi Yanagisawa
Background: Homeostasis of the vessel wall is cooperatively maintained by endothelial cells (ECs), smooth muscle cells, and adventitial fibroblasts. The genetic deletion of fibulin‐4 ( Fbln4 ) in smooth muscle cells ( SMKO ) leads to the formation of thoracic aortic aneurysms with the disruption of elastic fibers. Although Fbln4 is expressed in the entire vessel wall, its function in ECs and relevance to the maintenance of valvulo‐arterial integrity are not fully understood. Methods and Results: Gene silencing of FBLN4 was conducted on human aortic ECs to evaluate morphological changes and gene expression profile. Fbln4 double knockout ( DKO ) mice in ECs and smooth muscle cells were generated and subjected to histological analysis, echocardiography, Western blotting, RNA sequencing, and immunostaining. An evaluation of the thoracic aortic aneurysm phenotype and screening of altered signaling pathways were performed. Knockdown of FBLN4 in human aortic ECs induced mesenchymal cell–like changes with the upregulation of mesenchymal genes, including TAGLN and MYL9 . DKO mice showed the exacerbation of thoracic aortic aneurysms when compared with those of SMKO and upregulated Thbs1, a mechanical stress–responsive molecule, throughout the aorta. DKO mice also showed progressive aortic valve thickening with collagen deposition from postnatal day 14, as well as turbulent flow in the ascending aorta. Furthermore, RNA sequencing and immunostaining of the aortic valve revealed the upregulation of genes involved in endothelial‐to‐mesenchymal transition, inflammatory response, and tissue fibrosis in DKO valves and the presence of activated valve interstitial cells. Conclusions: The current study uncovers the pivotal role of endothelial fibulin‐4 in the maintenance of valvulo‐arterial integrity, which influences thoracic aortic aneurysm progression.

28 February 2020 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
TATakashi Anazawa
Takashi Anazawa
HMHiroko Matsunaga
Hiroko Matsunaga
SYShuhei Yamamoto
Shuhei Yamamoto
RIRyoji Inaba
Ryoji Inaba
Mutant (MT) in a large excess of wild type (WT) was quantified with high-sensitivity (LOD of 0.004% MT/WT) and four-orders-of-magnitude dynamic range (0.01–100% MT/WT) by a high-dynamic-range capillary-array electrophoresis (HiDy CE).

27 October 2025 in Cancer Immunology Research
Verified
Journal Article
Open access
DYDaisuke Yoshimoto
Daisuke Yoshimoto
HIHitoshi Iuchi
Hitoshi Iuchi
ATAyumi Taguchi
Ayumi Taguchi
KSKenbun Sone
Kenbun Sone
KTKana Tamai
Kana Tamai
YOYutaka Osuga
Yutaka Osuga
Human leukocyte antigen class I (HLA-I) is central to tumor immune recognition, but its regulatory mechanisms in cervical cancer remain poorly understood. This study aimed to elucidate the impact of HLA-I regulatory mechanisms on CD8+ T-cell infiltration and identify distinct histotype-specific immune escape strategies across cervical cancer subtypes. Using 98 cervical cancer cases, including squamous cell carcinoma (SCC; n = 53), adenocarcinoma (n = 32), gastric-type adenocarcinoma (GAS; n = 5), small cell carcinoma (Small, n = 4), and mixed histologic types (n = 4), we examined the relationship between CD8+ T-cell infiltration patterns (categorized as infiltrated, excluded, or absent) and HLA-I expression, HLA-A DNA methylation, and HLA-I loss of heterozygosity (LOH). CD8+ T-cell infiltration patterns varied significantly by histologic subtype (P < 0.0001). SCC showed the highest frequency of the infiltrated pattern (73.6%), whereas GAS and Small predominantly displayed an absent pattern. Reduced CD8+ T-cell infiltration correlated with poor survival (P < 0.0001). HLA-I expression mirrored these trends being highest in SCC and lowest in Small and GAS. HLA-A DNA methylation emerged as a key driver of HLA-I downregulation, leading to reduced CD8+ infiltration (P < 0.05). In SCC, both HLA-A methylation and HLA-I LOH contributed to immune evasion; cases lacking these alterations exhibited the highest CD8+ T-cell infiltration levels (P < 0.01). This study identifies distinct HLA-I regulatory mechanisms in cervical cancer, highlighting HLA-A methylation—and particularly HLA-I LOH in SCC—as key drivers of immune evasion. These findings provide a foundation for developing predictive biomarkers and suggest that targeting these specific HLA-I regulatory mechanisms could enhance immunotherapy efficacy.

28 July 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RKRyo Kakiuchi
Ryo Kakiuchi
TFTadanori Fukaya
Tadanori Fukaya
STSatomi Tamakoshi
Satomi Tamakoshi
STShohei Tsuji
Shohei Tsuji
HFHonoka Fujimori
Honoka Fujimori
THTasuku Hirayama
Tasuku Hirayama